| Q51412379 | Acute Myocardial Infarction Mortality During Dates of National Interventional Cardiology Meetings. |
| Q42376761 | Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study |
| Q94512145 | Bleeding risk of ticagrelor compared to clopidogrel in intensive care unit patients with acute coronary syndrome: A propensity-score matching analysis |
| Q56485189 | Cardiogenic Shock |
| Q53018824 | Clinical diagnosis of left ventricular dilatation and dysfunction in the age of technology. |
| Q35326877 | Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction |
| Q48003718 | Degree of dyspnoea in patients with non-ST-elevation acute coronary syndrome: A report from Japanese multicenter registry. |
| Q51543177 | Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation myocardial infarction |
| Q37680530 | Diagnosis and management of acute heart failure |
| Q30947051 | Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores |
| Q24236794 | Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era |
| Q84967217 | Effect of acute heart failure following discharge in patients with non-ST-elevation acute coronary syndrome on the subsequent risk of death or acute myocardial infarction |
| Q51252877 | Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability. |
| Q37453028 | Explicit risk in acute coronary syndrome management |
| Q92460700 | Frailty in Older Patients with Acute Coronary Syndrome in Vietnam |
| Q90248676 | Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome |
| Q41232859 | In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. |
| Q47820170 | Incidence, treatment strategies and outcomes of acute coronary syndrome with and without ongoing myocardial ischaemia: results from the CZECH-3 registry |
| Q42871558 | Killip classification and glucose level in patients with acute myocardial infarction |
| Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
| Q35581714 | Modern risk stratification in coronary heart disease. |
| Q64113211 | Relationship of the ORBIT and HAS-BLED scores with Killip class 3-4 in patients with ST-segment elevation myocardial infarction |
| Q55423937 | Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction. |
| Q38009702 | Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization? |
| Q26471900 | Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era |
| Q95643540 | Sex differences in myocardial infarction deaths |
| Q42431212 | Sex, Myocardial Infarction, and the Failure of Risk Scores in Women |
| Q40077869 | The influence of microvascular injury on native T1 and T2* relaxation values after acute myocardial infarction: implications for non-contrast-enhanced infarct assessment |
| Q51542235 | The prevalence and outcome of hypertension in patients with acute coronary syndrome in six Middle-Eastern countries |
| Q37293684 | The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients. |
| Q43606515 | The value of combining CYP2C19*2 polymorphism with classic risk factors in prediction of clinical prognosis in acute coronary syndrome patients |
| Q40363705 | Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan |
| Q34114946 | Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction |
| Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |